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 ABSTRACT
Introduction: Lesch-Nyhan síndrome (LNS) is an X-linked recessive inborn error of metabolism, due to deficiency of 
the enzyme Hypoxanthine-guanine-phosphoribosyl transferase (HGPRT; EC.2.4.2.8) resulting in hyperuricemia, neu-
rological and behavioural disturbances. In the present work, we report the results of the study of a Colombian family, 
where LNS was previously clinically and biochemically diagnosed. Material and Methods: The full HPRT gene, in-
cluding 9 exons and 8 introns, was amplified on eight separate DNA fragments.  Both strands, forward and reverse, 
of the amplified DNA fragments were analyzed and the obtained sequences were compared with those deposited at 
National Center for Biotechnology Information. Results and conclusions: Sequence analysis allowed the detection of 
new LNS causing mutation, an adenine deletion in exon 2 of HPRT1 gene resulting in a frameshift which determines 
a premature stop codon. This study, besides adding a new mutation to the already large spectrum of disease causing 
variation at HPRT, allows therefore providing genetic counseling for the family as well as prenatal diagnosis.
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INTRODUCTION
Lesch-Nyhan syndrome (LNS) is an X-linked recessive 
inborn error of metabolism, due to deficiency of the en-
zyme Hypoxanthine-guanine-phosphoribosyltransferase 
(HGPRT; EC.2.4.2.8) resulting in hyperuricemia, neu-
rological and behavioural disturbances. In the present 
work, we report the results of the study of a Colombi-
an family, where LNS was previously clinically and bio-
chemically diagnosed. Sequence analysis allowed the 
detection of new LNS causing mutation, an adenine de-
letion in exon 2 of HPRT1 gene resulting in a frame shift 
which determines a premature stop codon. 
The Lesch-Nyhan syndrome (LNS) is an inborn er-
ror of purine metabolism caused by a virtually complete 
deficiency (less than 1.5% of the normal level) of the 
enzyme Hypoxanthine-guanine phosphoribosy ltrans-
ferase (HGPRT) causing hyperuricemia and profound 
neurological disturbances (OMIM#300322). LNS is 
characterized by an overproduction of uric acid, neu-
rological dysfunction, varying degrees of learning dis-
ability, and some behavioral abnormalities including 
self-mutilation1. Three main phenotypic subgroups are 
recognized. The mostsevere subgroup is Lesch-Nyhan 
disease (LND), in which full classical syndromeoccurs. 
Least  affected  subgroup is HGPRT-related hyper-
uicemia (HRH), where patients exhibit overproductionof 
uric acid and show aresidual enzyme activity of 8%. In 
HRH the neurobehavioral features are absent or suffi-
ciently mild with no clinical significance. An intermedi-
ate subgroup is HGprt-relatedneurological dysfunction 
(HND), where patients exhibitoverproduction of uric acid 
along with varying degrees of neurologicalimpairments 
and display 1.5–8% of residual enzyme activity2.
The mutations are dispersed all over the gene, both 
in exons and intronic regions, and are very heteroge-
neous both in type and effects on HPRT activity2. How-
ever, recent studies have revealed multiple unrelated 
patients with similar mutations, providing an opportunity 
to examine genotype–phenotype correlations3.
HPRT gene is located on X chromosome, at 
Xq26-q27 region, and consists of nine exons and eight 
introns, spanning 45 kb4; the mRNA transcript is 1.6 kb 
long, encoding a protein with 218 amino acids1. More 
than 400 different causing HPRT deficiency mutations 
have been described, including a total of 250 responsi-
ble for LNS. As a consequence of the sex-linked mode of 
transmission LNS affects almost exclusively males and 
an allele frequency of approximately 2x10-3 is responsi-
ble for anestimated incidence at birth of 1/380,000.
Although there are many reports on families carrying 
the LNS, until now a single case has been described for 
a Colombian family. Two affected members of this fam-
ily were first clinically diagnosed in 19925 and later they 
were characterized biochemically6. Subsequently anal-
ysis of alleles at an STR locus in intron 3 of the HPRT 
gene were performed in 16 members from this family in 
order to establish the carrier statues of the women7. In 
this work we report the results of the sequencing study 
on this Colombian family with members affected by 
LNS, which revealed a new mutation at HPRT locus.
MATERIALS AND METHODS
The genealogy of the studied family is shown in Figure 
1. Samples were collected after informed consent. DNA 
was extracted from total blood by salting-out8. Kinship 
was confirmed using apreviously described protocol for 
the amplification of 10 X chromosome STRs9,10.
Figure 1.The genealogy of the family with Lesch-Nyhan syndrome. 
Greyed symbols correspond to affected individuals; a smaller circle 
to a newborn death; arrows point to the proposita. Note that all coded 
individuals, except LN17, were sequenced.
The full HPRT gene, including 9 exons and 8 introns, 
was amplified on eight separate DNA fragments follow-
ing a previous described protocol11. Both strands, for-
ward and reverse, of the amplified DNA fragments were 
sequenced employing Big Dye Terminator Cycle Se-
quencing Kit (Applied Biosystems) in an ABI PRISM 377 
DNA sequencer (Applied Biosystems)12. Obtained se-
quences were compared with those deposited at NCBI4.
RESULTS
Complete sequencing of the 9 exons and 8 introns of 
HPRT gene of both affected individuals, has revealed 
an adenine deletion at position 52 of exon 2. No other 
variation previously associated with the disease was 
found. The sequencing results of the affected male 
and a normal homozygote female are shown in Fig 2 
and Fig 3 respectively.
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Figure 2.  Sample of a woman homozygous for the normal sequence 
of exon 2 of HPRT1 gene.
Figure 3.Sample of a male hemizygous for the sequence with the de-
letion of adenine at position 52 of exon 2 of HPRT1 gene.
This deletion causes a shift of the reading frame in Y17 
and generates a stop codon at 41. Figure 2 shows the se-
quencing of an analyzed sample of a homozygous for the 
normal sequence of exon 2.  Figure 4 shows the sequenc-
es of the normal allele and the mutated one for a carrier.
DISCUSSION AND CONCLUSIONS:
Sequencing of theen tire HPRT gene in this family mem-
bers allowed the discovery of a new mutation at exon 2, 
an adenine deletion determining a premature codon stop 
at position 41 of this exon. Although other mutations at 
codon 2 were previously reported, none corresponds to 
the variant here described13,14. The diagnosis in patients 
LN02 and LN04 was confirmed and we were able to trace 
the transmission of the mutation in the family and namely 
to establish the carrier status of females (LN01, LN09, 
LN06, LN10, LN12).This study, besides adding a new 
mutation to the already large spectrum of disease caus-
ing variation at HPRT, allows therefore providing genetic 
counseling for the family as well as prenatal diagnosis7.
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